marijuana stocks news

Lifestyle Delivery Systems Inc. Announces its Affiliate, CSPA Group, Inc., has Received an Open Purchase Order for 300 Litres of Distillate a Month

Lifestyle Delivery Systems Inc. (LDS.CN), (LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces that its affiliate, CSPA Group, Inc. (“CSPA”), has received an open purchase order for 300 litres of high quality distillate per month through December 2018.

CSPA will supply the biomass and the processing for the extraction and distillation. The finished high-grade distillate will be capable of filling up to 300,000 one-gram vape pen cartridges.  LDS’s CEO, Brad Eckenweiler, stated, “This purchase order emphasizes the acceptability in the market for a dependable high quality white label producer. A producer capable of supplying established brands with the highest quality finished material and allowing those brands to focus their resources on marketing and building their brand with the assurance that they have the highest quality ingredients.” The Company will continue its development of processes and product lines as well as building its white label business.

About Lifestyle Delivery Systems Inc.

Lifestyle Delivery Systems Inc. is a licensed, state-compliant, vertically integrated cannabis-related company.  From our isogenic pollination nursery to our cutting edge, state-of-the-art production facility located in Southern California, LDS has become one of the most diverse, innovative and scientifically based cannabis companies throughout North America. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. From start to finish, the production process tests for quality and composition of all the ingredients used in each and every strip, resulting in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Brad Eckenweiler
CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT:
investor.relations@lifestyledeliverysystem.com
1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970.  Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

INSYS Therapeutics, Inc. (INSY)and UC San Diego’s Center for Medicinal Cannabis Research Add Anxiety in Anorexia Nervosa to Series of Collaborative (CBD) Studies

INSYS Therapeutics and UC San Diego’s Center for Medicinal Cannabis Research Add…

Hemp, Inc. (HEMP) Reports Oklahoma Next to Allow Commercial Production of Industrial Hemp

Hemp, Inc. Reports Oklahoma Next to Allow Commercial Production of Industrial Hemp…

$SRNA Announces Retirement of Shares, Settlement of Debt

Surna, Inc. Announces Retirement of Shares, Settlement of Debt  Surna, Inc. (SRNA),…

CannTrust™ (CNTTF) reports record revenue for Q1 2018

CannTrust™ reports record revenue for Q1 2018 CannTrust Holdings Inc. (“CannTrust” or…